Big Brains
Big Brains
University of Chicago Podcast Network
Translating groundbreaking research into digestible brain food. Big Brains, little bites. Produced by the University of Chicago Podcast Network & Winner of CASE "Grand Gold" award in 2022, Gold award in 2021, and named Adweek's "Best Branded Podcast" in 2020.
How To Manifest Your Future Using Neuroscience, with James Doty
We've all heard the phrase "Manifest Your Destiny" when it comes to wanting that new promotion, figuring out a new career path or just trying to achieve that long-term goal. It turns out that the act of manifestation is not merely pseudoscience—it actually has a body of research in neuroscience to back it up. Dr. James Doty has been exploring this topic throughout his career; and offers scientific research as well as tools on how to manifest your goals in his new book, Mind Magic: The Neuroscience of Manifestation and How It Changes Everything. James Doty is a clinical professor of neurosurgery at Stanford University, where is also the founder and director of the Center for Compassion and Altruism Research and Education. He explores how manifestation is not only a tool to achieve what we want, but it is also fundamentally about being selfless and caring for others in order to activate our deep internal happiness. Link to the advertised Chicago Booth Review Podcast: https://www.chicagobooth.edu/review/podcast?source=cbr-sn-bbr-camp:podcast24-202405/02
May 2
31 min
Why We Die—And How We Can Live Longer, with Nobel Laureate Venki Ramakrishnan
They’re perhaps the oldest questions in the science: Why do we die? And could we find a way to live forever? But for decades, anti-aging research was a “backwater” of the scientific community, consider too fanciful and unrealistic. That is until the last few years. Modern advances in biology have taught us a lot about how we age and why we die—could that knowledge help us turn back the clock? In his new book, “Why We Die: The New Science of Ageing and the Quest for Immortality”, Nobel Prize-winning scientist Venki Ramakrishnan delves into the latest science of aging and investigates the nearly $30 billion dollar longevity industry to separate fact from fiction in our modern quest for immortality.
Apr 18
32 min
What Dogs Are Teaching Us About Aging, with Daniel Promislow
Every dog owner has faced the hard realization that their dog won’t live as long as they do, but we’ve all probably wondered: Why do some dogs live longer than others? It turns out that several factors are at play, according to the largest research study of dogs, known as The Dog Aging Project. Prof. Daniel Promislow of the University of Washington is co-director of the project, which examines how biology, lifestyle and environment can increase both the health and lifespan of more than 50,000 dogs. We spoke with Promislow about whether we can help our dogs live longer—and what their research could actually teach humans about aging. Link to the advertised Chicago Booth Review Podcast: https://www.chicagobooth.edu/review/podcast?source=cbr-sn-bbr-camp:podcast24-20240404
Apr 4
32 min
Where Has Alzheimer’s Research Gone Wrong? with Karl Herrup
For more than a century, scientists have been studying Alzheimer’s disease and developing theories about its underlying cause. The leading theory for decades has been that abnormal amyloid plaques in the brains of those who suffer from the disease are the central cause. But, according one renowned Alzheimer’s researcher, this myopic focus is not only flawed, but may be holding back our search for a cure. Neurobiologist Karl Herrup argues that we need to go back to the drawing board, redefine the disease and understand the many factors that could cause it before we can race for a cure. A professor of neurobiology and an investigator in the Alzheimer’s Disease Research Center at the University of Pittsburgh School of Medicine, Herrup is the author of How Not to Study a Disease: The Story of Alzheimer’s.
Mar 21
29 min
Why Breeding Millions of Mosquitoes Could Help Save Lives
Mosquito-borne diseases are one of the greatest global health threats, infecting around 700 million people every year with Zika virus, dengue fever, malaria and yellow fever — which can all be deadly if left untreated. Unfortunately, the mosquito population is not slowing down, and factors like climate change and increased global travel are broadening the mosquito's range. The effort to stop the mosquito is not an easy task; insecticides and vaccines can't completely stop the spread of these diseases. But instead of trying to kill mosquitoes, one nonprofit is taking a unique approach. Scientist Scott O'Neill is founder and CEO of the World Mosquito Program, a nonprofit group with the goal of eliminating mosquito-borne diseases. The program is implementing a new method of inoculating the wild population of mosquitoes with a bacteria called Wolbachia, which is resistant to diseases. So far, the program has been rolled out in countries like Brazil, Colombia, Indonesia, Australia and Mexico – and has already seen success in reducing rates of disease. Link to the advertised Chicago Booth Review Podcast: https://www.chicagobooth.edu/review/podcast?source=cbr-sn-bbr-camp:podcast24-20240307
Mar 7
30 min
Why Shaming Other Countries Often Backfires, with Rochelle Terman
How do you stop a government from continuing to commit human rights abuses? You could take them to an international court of justice, or file a complaint at the UN. But none of those bodies have any enforcement power. Short of going to war, the only option on the table in most international situations is to name and shame. But is that strategy effective? In her new book, “The Geopolitics of Shaming: When Human Rights Pressure Works and When It Backfires,” University of Chicago political scientist Rochelle Terman argues that there is a real dilemma to international human rights pressure: Shaming is most common in situations where it is least likely to be effective; and, most troublingly, it can often make human rights abuses worse. Link to the advertised Chicago Booth Review Podcast: https://www.chicagobooth.edu/review/podcast?source=cbr-sn-bbr-camp:podcast24-20240222
Feb 22
33 min
Can Trump Legally Be President?, with William Baude
The Supreme Court’s decision on whether Colorado can take former President Donald Trump off the ballot in the 2024 election may be one of the most consequential in its history. The case will turn on the court’s interpretation of Amendment 14, Section 3 of the Constitution, which bars any previous elected official from holding office if they participated in an insurrection. When making their case, Colorado followed the logic of a law review article co-authored last year by University of Chicago Prof. William Baude. The article drew a ton of attention, in part because Baude is a conservative legal scholar and member of the Federalist Society. As the Supreme Court begins oral arguments on Feb. 8, Baude joined Big Brains to make his case for why he thinks Section 3 applies to Trump. But this isn’t an episode about what should happen at the Supreme Court, it’s about what could happen. Whether you agree with Baude or not, understanding the legal theory behind his argument is crucial to understanding any decision that may come from the court. And, as we walk through the scholarship on Section 3, it’ll become clear that there are more than just two outcomes: on or off the ballot, but many outcomes…some with ramifications—including a possible constitutional crisis—all the way to Jan. 6, 2025.
Feb 6
36 min
What Our Hand Gestures Reveal About Our Thoughts, with Susan Goldin-Meadow
Language shapes our world. But when we speak, there is actually a secret conversation happening beyond our words. It’s happening not with our mouths—but with our hands. Prof. Susan Goldin-Meadow is a distinguished scholar of psychology at the University of Chicago. Her research into deaf children who were never taught sign language led her to studying why the gestures we do all day may contain more information about our minds than we realize. Now she’s included all her insights in a new book, “Thinking With Your Hands—The Surprising Science Behind How Gestures Shape Our Thoughts.”
Jan 25
26 min
Psychedelics Without Hallucinations: A New Mental Health Treatment? with David E. Olson
The United States is facing a real mental health crisis. In the last few years, one possible treatment has gotten a lot of press: psychedelic drugs. But what is actually happening in a person’s brain when they take a psychedelic? Could understanding the biology and the chemistry allow us to make better and safer versions of these drugs—and maybe even create psychedelics without the hallucinations? In this episode, we speak with Assoc. Prof. David E. Olson, founding director of the UC Davis Institute of Psychedelics and Neurotherapeutics. Olson and his lab have been researching the therapeutic effects of psychedelic drugs and how they could be used to treat neuropsychiatric diseases, including depression, anxiety disorders and even addiction. His lab’s is researching how to develop non-hallucinogenic psychedelics, also called next-generation neurotherapeutics.
Jan 11
32 min
The Science Of Happiness
The Big Brains team is taking some time off during the holidays but for all those travelers out there heading home, we wanted to make sure you still had your favorite podcast in your feed. So, we’re resharing one of our most popular episodes ever. It’s about the science of happiness. What is the key to living a happy and fulfilling life? The answer is actually quite simple, according to the two scholars behind the longest scientific study of happiness every conducted. Beginning in 1938, the Harvard Study of Adult Development tracked three generations of families to uncover what contributed to their happiness. In their new book, The Good Life: Lessons from the World's Longest Scientific Study of Happiness, Robert Waldinger and Marc Schulz tell the stories behind their participants' lives and provide key insights on the recipe to happiness. Marc Schulz, a professor at Bryn Mawr College, joins the podcast to discuss the book and their study.
Dec 28, 2023
29 min
Load more